Chengdu Bright Eye Hospital Co. Ltd.
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 32.38 CNY | 48,32 CNY | 28,35 CNY |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - CNY | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 149.619.048 | - | - |
Beschreibung
(automatisch übersetzt)
Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrimal duct surgery, and corneal diseases treatment, as well as low vision and visual rehabilitation. It is also involved in medical, hospital, and investment management; ophthalmological research; sale of medical instruments and eyeglasses; cultural propagation; engineering renovation; and technology development. The company was formerly known as Chengdu Bright Eye Hospital Group Co., Ltd. and changed its name to Bright Eye Hospital Group Co., Ltd. in June 2025. Bright Eye Hospital Group Co., Ltd. was founded in 2005 and is headquartered in Chengdu, China.
| Allgemein | Profitabilität | ||
|---|---|---|---|
| Industriesektor ? | Gesundheitsunterstützende Dienstleistungen | Operative Marge [%] ? | - |
| Marktkapitalisierung ? | - CNY | ROIC [%] ? | - |
| Enterprise Value ? | - CNY | ROIC/WACC ? | - |
| Bewertung | |||
| KGV [TTM] ? | - | EV/FCFF [TTM] ? | - |
| KGV [Forward] ? | - | EV/Sales [TTM] ? | - |
| KUV [TTM] ? | - | EV/EBITDA [TTM] ? | - |
| KBV [TTM] ? | - | ||
| Finanzielle Risiken und Liquidität | |||
| Künstl. Bonität ? | - | Zinsdeckungsgrad ? | - |
| Verschuldungsgrad [Buch] ? | - | Cash Ratio - L1 ? | - |
| Verschuldungsgrad [Markt] ? | - | Quick Ratio - L2 ? | - |
| Current Ratio - L3 ? | - | ||
| Dividenden und Aktienrückkäufe | |||
| Vergangene Jahresdividende ? | - CNY | Ausschüttungsquote ? | - % |
| Erwartete Jahresdividende ? | - CNY | Erwartete Dividendenrendite ? | - % |
| Netto Aktienrückkäufe [TTM] ? | - CNY | Effektive Ausschüttungsquote ? | - % |
| Dividendenauszahlung [TTM] ? | - CNY | Effektive Auszahlungsrendite ? | - % |
| Netto Gesamtauszahlung [TTM] ? | - CNY | ||
Kennzahlen
Gewinn/Verlust
Cash Flow
Dividenden & Aktienrückkäufe
Bilanz
Vergleichbare Unternehmen
| Name | Takani Score ? | Marktkapitalisierung | Industriesektor | Land/Region | KGV TTM | Forward KGV ? | |
|---|---|---|---|---|---|---|---|
| Huaxia Eye Hospital Group Co. Ltd. A | 57,2 | 1.956.552.492,339 USD | Gesundheitsunterstützende Dienstleistungen | China | 28.67 | - | |
| Meinian Onehealth Healthcare Holdings Co Ltd | 28,24 | 2.613.171.355,648 USD | Gesundheitsunterstützende Dienstleistungen | China | 64.57 | 20.45 | |
| Aier Eye Hospital Group | 72,02 | 11.839.963.226,112 USD | Gesundheitsunterstützende Dienstleistungen | China | 23.94 | 41.84 | |
| Jinxin Fertility Group Ltd | 14,82 | 719.339.838,72 USD | Gesundheitsunterstützende Dienstleistungen | China | - | 13.3 | |
| Gushengtang Holdings Ltd | 69,25 | 770.094.516,48 USD | Gesundheitsunterstützende Dienstleistungen | China | 16.95 | 10.79 | |
| Hygeia Healthcare Holdings Co Ltd | 38,47 | 775.010.688 USD | Gesundheitsunterstützende Dienstleistungen | China | 32.32 | - | |
| Hengkang Medical Group Co Ltd | 21,99 | 1.070.682.508,493 USD | Arzneimittel (Pharmazeutisch) | China | 210 | 38.31 | |
| Xian International Medical Investment Co Ltd | 47,77 | 1.388.877.066,035 USD | Einzelhandel (Allgemein) | China | - | 33.33 | |
| Top Choice Medical Investment Co Inc | 63,01 | 2.285.835.108,659 USD | Gesundheitsunterstützende Dienstleistungen | China | 30.89 | 54.05 | |
| Arrail Group Ltd | 26,55 | 131.150.914,56 USD | Gesundheitsunterstützende Dienstleistungen | China | 30.5 | - |